Clinical Trial Update: Nexium Dyspepsia/AST [Phase 3]

View source ↗

Summary

Nexium, esomeprazole, was studied in a Phase 3 trial for dyspepsia. The study status is completed according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastrointestinal Disease, Signs and Symptoms, Digestive | Phase 3 | Status: COMPLETED